Opportunity for #GMP Process Technician at Seda Pharmaceutical Development Services (Cheadle, South Manchester UK) ref: REF0125 | closing: 28-Oct-2025 #DrugDev #chemsky π§ͺ
sedacms.com/vacancy/gmp-...
Latest posts tagged with #drugDev on Bluesky
Opportunity for #GMP Process Technician at Seda Pharmaceutical Development Services (Cheadle, South Manchester UK) ref: REF0125 | closing: 28-Oct-2025 #DrugDev #chemsky π§ͺ
sedacms.com/vacancy/gmp-...
𧬠Molecule magic! #MolecularModelling accelerates drug discovery & protein engineering π»π¬
#ComputationalBiology #PharmaTech #DrugDev
www.marketresearchfuture.com/reports/mole...
Chirality matters. Miss it, and drug safety & efficacy suffer. With #HRIM-MS, our customers resolve enantiomers others canβt, saving costs & improving outcomes. We are proud to share what our customers are up to here: view-su2.highspot.com/viewer/766d6....
#Chirality #DrugDev #MassSpec #MOBIE
Oligo therapeutics hold promise, but PS modifications create a tangle of stereoisomers that are hard to resolve. Genentech scientists used #SLIM-based #HRIM-MS to finally separate them, enabling smarter design, better control, and safer drugs.
#RNAi #Oligos #MassSpec #DrugDev #CustomerImpact
Check out our Behind-The-Paper article talking about the intersection of #aging target research and drug dev to fill a desperate clinical need for patients with no curative therapeutic options:
communities.springernature.com/posts/ai-mee...
#IPF #drugdev #AI #genAI
For some context, we have known for >10 yrs that colibactin (the toxin) induces DNA damage/mutations that would likely drive cancer.
Emily Balskus' work, among others, demonstrated this.
But we are unlikely to have a treatment anytime soon. What gives?
#microbiome #drugDev #infectiousDisease
Data slide on J&J new drug delivery advice for bladder cancer, which happens to look like a pretzel.
I know bladder cancer is a serious, terrible disease.
But at the same time this J&J slide popped up and I thought: "Would you like a bladder pretzel?"
#drugDev #pharma #ImSorry
Some of our recent work on models to design molecular glues, PROTACs (and really anything that forms a protein-protein complex) -- presented by Aram Davtyan at Keystone on Proximity-based Therapeutics this week!
#targetedDegradation #PROTAC #molecularGlue #drugDev #drugDesign #biotech #bioSky
Aram Davtyan giving an awesome poster presentation about our work modeling protein-small molecule-protein ternary complexes at @keystonesymposia.bsky.social Proximity-Based Therapeutics! #biotech #drugDev #degraders #molecularGlues #PROTACs
Find the poster here: www.deeporigin.com/academic-pos...
For those working in #cellTherapy, Ori Biotech has created tracker of all patients treated with commercially-available cell therapies.
It hovers around 33,000.
#biotech #pharma #drugDev
oribiotech.com/insight/pati...
Something I am always baffled by: Center for Biologics Evaluation and Research (CBER) in the FDA does *NOT* regulate antibody or other protein therapies.
That's done by Center for Drug Evaluation and Research (CDER) - even though they're biologics.
pmc.ncbi.nlm.nih.gov/articles/PMC...
#drugDev
Ned David (founder at Syrrix, Kythera, Achaogen, Unity Bio) on founding biotechs, being a drug hunter, and lessons he's learned:
1) capital excess is death
2) do the experiment that would destroy the idea first
3) do not go public unless you're absolutely ready
#biotech #startup #bioSky #drugDev
Hi there, just joined. π Feels better here already #MedSky #ScienceSky #drugdev
I'm learning some pharmacology, and I don't know if the pharmacologists can be trusted with acronyms.
They have created: PK/PD, PBPK, PBAM, PBBM, QSP, QST...all of which are related but different concepts or frameworks.
Plz folks, no more P's and B's at least.
#pharmacology #bioSky #drugDev
We talk a lot about the reasons drug candidates fail, but I feel like we don't talk enough about WHY specific candidates fail.
Things like "lack of efficacy" or "tox" aren't really actionable. Was it binding affinity? Binding to a homolog? Metabolized too fast? A mix?
#BioSky #ChemSky #drugDev
Opportunity for #formulation scientist at Seda Pharmaceutical Development Services (Manchester UK) ref: REF 1024 | closing 31-Jul-2024 #DrugDev π§ͺ
www.sedapds.com/vacancy/seni...